Embryo quality in ovarian stimulation with hMG
This trial tests how well a hormone treatment (hMG) works for people doing IVF with genetic screening of embryos. It may help if you have normal ovarian reserve and are not using donor sperm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have genetic testing on your embryos before transfer.
- Your AMH level is between 0.5 and 3.5 ng/ml, or your antral follicle count is between 5 and 20.
- Your BMI is between 18.5 and 30.
- Both you and your partner have normal chromosomes (karyotypes).
- You haven't had a poor response to fertility drugs in the past (3 or fewer eggs retrieved).
- Your partner does not need surgery to retrieve sperm (TESE).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.